PATENT CLAIM ANALYSIS

Application Number: 16062653
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "013500"]

Abstract:
The present invention relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics.

Claim (Index 22):
The method of  claim 16 , wherein the T max  of R5000 in subject plasma is from about 1 hour to about 48 hours.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.2381
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15905158', '15547085', '13830831', '15318063', '14042205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7208040465270417
- 35 USC 102 Novelty (BERT): 0.5270773120106309
- Combined Prediction Score: 0.7014313730754006
- Mean Citation Score: 271.10195600000003
- Max Citation Score: 320.84573
- Similarity Product: 204.62375316508235

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test